These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 14620649)
21. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial. Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210 [TBL] [Abstract][Full Text] [Related]
22. A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results. Haggsträm FM; Chatkin JM; Sussenbach-Vaz E; Cesari DH; Fam CF; Fritscher CC Pulm Pharmacol Ther; 2006; 19(3):205-9. PubMed ID: 16517193 [TBL] [Abstract][Full Text] [Related]
23. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791 [TBL] [Abstract][Full Text] [Related]
24. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies? Chatkin JM; Mariante de Abreu C; Haggsträm FM; Wagner MB; Fritscher CC Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876 [TBL] [Abstract][Full Text] [Related]
25. A randomized trial of smoking cessation. Medication versus motivation. Uyar M; Filiz A; Bayram N; Elbek O; Herken H; Topcu A; Dikensoy O; Ekinci E Saudi Med J; 2007 Jun; 28(6):922-6. PubMed ID: 17530112 [TBL] [Abstract][Full Text] [Related]
26. Clinical effectiveness of sustained-release bupropion and behavior therapy for tobacco dependence in a clinical setting. Earles J; Folen RA; Ma M; Kellar M; Geralde R; Dydek Co Mil Med; 2002 Nov; 167(11):923-5. PubMed ID: 12448619 [TBL] [Abstract][Full Text] [Related]
28. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling. McCarthy DE; Piasecki TM; Lawrence DL; Jorenby DE; Shiffman S; Fiore MC; Baker TB Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of bupropion alone and in combination with nicotine gum. Piper ME; Federman EB; McCarthy DE; Bolt DM; Smith SS; Fiore MC; Baker TB Nicotine Tob Res; 2007 Sep; 9(9):947-54. PubMed ID: 17763111 [TBL] [Abstract][Full Text] [Related]
30. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial. Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238 [TBL] [Abstract][Full Text] [Related]
31. Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome. Swan GE; Jack LM; Curry S; Chorost M; Javitz H; McAfee T; Dacey S Nicotine Tob Res; 2003 Dec; 5(6):911-21. PubMed ID: 14668075 [TBL] [Abstract][Full Text] [Related]
32. A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year. Grassi MC; Enea D; Ferketich AK; Lu B; Nencini P Nicotine Tob Res; 2009 Sep; 11(9):1114-21. PubMed ID: 19654237 [TBL] [Abstract][Full Text] [Related]
33. An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects. Wilcox CS; Oskooilar N; Erickson JS; Billes SK; Katz BB; Tollefson G; Dunayevich E Addict Behav; 2010 Mar; 35(3):229-34. PubMed ID: 19926400 [TBL] [Abstract][Full Text] [Related]
34. [Bupropion as an aid for smoking cessation]. Tonstad S Tidsskr Nor Laegeforen; 2002 Nov; 122(27):2612-5. PubMed ID: 12523190 [TBL] [Abstract][Full Text] [Related]
35. Drug therapy to aid in smoking cessation. Tips on maximizing patients' chances for success. Dale LC; Hurt RD; Hays JT Postgrad Med; 1998 Dec; 104(6):75-8, 83-4. PubMed ID: 9861257 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR; JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547 [TBL] [Abstract][Full Text] [Related]
37. Changes in health-related quality of life with smoking cessation treatment. Hays JT; Croghan IT; Baker CL; Cappelleri JC; Bushmakin AG Eur J Public Health; 2012 Apr; 22(2):224-9. PubMed ID: 20884658 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652 [TBL] [Abstract][Full Text] [Related]
39. [Bupropion combined with nicotine patches in smoking cessation]. Sampablo Lauro I; Lores L; Coll F; Rebasa P Arch Bronconeumol; 2000; 36(7):377-80. PubMed ID: 11000926 [TBL] [Abstract][Full Text] [Related]